US Patent Issued to Neurocrine Biosciences on Aug. 12 for "CRF receptor antagonists and methods of use" (California Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,536, issued on Aug. 12, was assigned to Neurocrine Biosciences Inc. (San Diego).

"CRF receptor antagonists and methods of use" was invented by Evan Smith (San Diego), Sha Luo (San Diego), Gordon Raphael Loewen (San Diego), Neil J. Ashweek (San Diego) and John P. Williams (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds are provided herein, as well as related preparations, compositions and methods for treating diseases and/or disorders that would benefit from the same such as congenital adrenal hyperplasia (CAH)."

The patent was filed on Sept. 25, 2020, under Application No. 17/764,050.

*For further information, including images,...